Document is current
Any future updates will be listed below
-
Authors
Kapulu, Melissa C. https://orcid.org/0000-0003-0321-7128
Kimani, Domtila
Njuguna, Patricia
Hamaluba, Mainga
Otieno, Edward
Kimathi, Rinter
Tuju, James
Sim, B. Kim Lee
,
Abdi, Abdirahman I.
Abebe, Yonas
Bejon, Philip
Billingsley, Peter F.
Bull, Peter C.
de Laurent, Zaydah
Hoffman, Stephen L.
James, Eric R.
Kariuki, Silvia
Kinyanjui, Sam
Kivisi, Cheryl
Makale, Johnstone
Marsh, Kevin
Mohammed, Khadija Said
Mosobo, Moses
Musembi, Janet
Musyoki, Jennifer
Muthui, Michelle
Mwacharo, Jedidah
Mwai, Kennedy
Ngoi, Joyce M.
Ngoto, Omar
Nkumama, Irene
Ndungu, Francis
Odera, Dennis
Ogutu, Bernhards
Olewe, Fredrick
Omuoyo, Donwilliams
Ong’echa, John
Osier, Faith
Richie, Thomas L.
Shangala, Jimmy
Wambua, Juliana
Williams, Thomas N.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02739763 at ClinicalTrials.govDocuments that mention this clinical trial
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
https://doi.org/10.1186/s12879-022-07044-8
The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study
https://doi.org/10.7554/elife.83874
-
Funding
Funding for this research was provided by:
wellcome trust (107499)
- License Information
-
More Information
Article History
Received: 9 August 2021
Accepted: 11 January 2022
First Online: 24 January 2022
Declarations
:
: The study was conducted at the KEMRI Wellcome Trust Research Programme in Kilifi, Kenya and received ethical approval from the KEMRI Scientific and Ethics Review Unit (KEMRI//SERU/CGMR-C/029/3190) and the University of Oxford Tropical Research Ethics Committee (OxTREC 2-16). The study was registered on ClinicalTrials.gov (NCT02739763), conducted based on good clinical practice (GCP), and under the principles of the Declaration of Helsinki. Consent to participate in the study by all study volunteers was provided by written consent.
: Not applicable.
: B. K. L. S. is a salaried, full-time employee of Sanaria Inc., the manufacturer of Sanaria PfSPZ Challenge. Thus, all authors associated with Sanaria Inc. have potential conflicts of interest. All other authors declare no competing interests.
